Tübingen, Germany

Hans Zahner

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Zahner. Retrieved from https://idiyas.com/inventor/hans-zahner-4tsmj2qu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hans Zahner

Introduction

Hans Zahner is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of antibiotics, particularly with his work on polycyclic peptide antibiotics. His innovative approach has led to the development of a new antibiotic that holds promise for medical applications.

Latest Patents

Hans Zahner holds a patent for a polycyclic peptide antibiotic known as gallidermin. This antibiotic is produced through the fermentation of a newly identified microorganism, Staphylococcus gallinarum (DSM 4616). The patent highlights the unique properties of gallidermin and its potential uses in combating bacterial infections.

Career Highlights

Throughout his career, Zahner has focused on microbiology and antibiotic development. His work has been instrumental in advancing the understanding of peptide antibiotics and their applications in medicine. With a patent portfolio that includes 1 patent, he has established himself as a key figure in the field.

Collaborations

Hans Zahner has collaborated with notable colleagues such as Friedrich Gotz and Hermann Allgaier. These partnerships have contributed to the success of his research and the development of innovative solutions in antibiotic therapy.

Conclusion

Hans Zahner's contributions to the field of antibiotics, particularly through his invention of gallidermin, showcase his innovative spirit and dedication to advancing medical science. His work continues to inspire future research in antibiotic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…